Six-Month Pilot Study Demonstrates Improved Guideline Adherence Following Implementation of Standardized Cirrhosis Clinical PathwayPRNewsWire • 10/12/26
Bausch + Lomb and Bausch Health Announce Appointment of Thomas J. Appio as Interim Bausch + Lomb CEO, Expect to Raise Full-Year 2026 GuidanceBusiness Wire • 10/12/26
4 Low-Beta Healthcare Stocks to Buy Amid Fears of Another Rate HikeZacks Investment Research • 10/02/26
Consumer Confidence Falls Amid Ongoing Geopolitical Tensions: 4 PicksZacks Investment Research • 09/30/26
Bausch Health and YUN Announce Expansion to Mexico and Across Additional EMEA MarketsPRNewsWire • 09/08/26
Bausch Health's Ortho Dermatologics Announces the 2026 Aspire Higher Scholarship WinnersPRNewsWire • 08/27/26
Bausch + Lomb Advancing Two First-in-Class Eye Health Therapies Based on Trial ResultsBusiness Wire • 08/24/26
Bausch + Lomb: The Market Is Pricing The Balance Sheet, Not The Eye-Care EngineSeeking Alpha • 08/20/26
Why Bausch Health (BHC) is a Top Momentum Stock for the Long-TermZacks Investment Research • 08/11/26
BHC Q2 Earnings Beat Estimates on Salix and Solta Growth, '26 View RaisedZacks Investment Research • 07/30/26